Systematic review of the clinical and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer.
Citation
Mowatt , G , Zhu , S , Kilonzo , M , Boachie , C , Fraser , C , Griffiths , T R L , N'Dow , J , Nabi , G , Cook , J & Vale , L 2010 , ' Systematic review of the clinical and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer. ' , Health Technology Assessment , vol. 14 , no. 4 , pp. 1-353 . https://doi.org/10.3310/hta14040